Colour Doppler in IUGR- Where are we and where do we go?

被引:0
|
作者
Lulla C. [1 ]
Garg S. [1 ]
机构
[1] Dept. of Ultrasonography, Jaslok Hospital and Research Centre, Mumbai
关键词
Doppler based management in IUGR Aortic Isthmus; Fetal circulatory changes in IUGR; Intra uterine growth restriction;
D O I
10.1007/s13224-010-0047-7
中图分类号
学科分类号
摘要
Intra-uterine growth restriction (IUGR) is an important perinatal problem giving rise to increased morbidity and mortality in the growth restricted fetus. The aim of fetal medicine today, is to prevent the mere occurrence of IUGR in high risk pregnancies and to deliver the fetuses already afflicted with growth restriction, before they have suffered from the effects of hypoxia. The use of Doppler provides this information, which is not readily obtained from the other conventional tests of fetal well being. The Doppler patterns follow a longitudinal trend in the arterial and venous circulation of the fetus as well as the placental vasculature guiding management decisions regarding the appropriate time of delivery. Progressive knowledge of the fetal circulation and its adaptation when the fetus is subjected to hypoxia, has helped us recognize the early signs of IUGR thereby improving the prognosis of these complicated pregnancies. It has therefore become the gold standard in the management of the growth-restricted fetus.
引用
收藏
页码:301 / 311
页数:10
相关论文
共 50 条
  • [1] TAKEOVERS - WHERE ARE WE - WHERE DO WE GO
    SUBAK, JT
    [J]. BUSINESS LAWYER, 1986, 41 (04): : 1255 - 1264
  • [2] Gephyrin: where do we stand, where do we go?
    Fritschy, Jean-Marc
    Harvey, Robert J.
    Schwarz, Guenter
    [J]. TRENDS IN NEUROSCIENCES, 2008, 31 (05) : 257 - 264
  • [3] Influenza vaccine: Where are we and where do we go?
    Keshavarz, Mohsen
    Mirzaei, Hamed
    Salemi, Maryam
    Momeni, Fatemeh
    Mousavi, Mohammad Javad
    Sadeghalvad, Mona
    Arjeini, Yaser
    Solaymani-Mohammadi, Farid
    Nahand, Javid Sadri
    Namdari, Haideh
    Mokhtari-Azad, Talat
    Rezaei, Farhad
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2019, 29 (01)
  • [4] NISQ computing: where are we and where do we go?
    Lau, Jonathan Wei Zhong
    Lim, Kian Hwee
    Shrotriya, Harshank
    Kwek, Leong Chuan
    [J]. AAPPS BULLETIN, 2022, 32 (01):
  • [5] The metabolic syndrome: Where are we and where do we go?
    Roth, JL
    Mobarhan, S
    Clohisy, M
    [J]. NUTRITION REVIEWS, 2002, 60 (10) : 335 - 337
  • [6] Transgenic fish - Where we are and where do we go?
    Dunham, Rex A.
    Liu, Zhanjiang
    [J]. ISRAELI JOURNAL OF AQUACULTURE-BAMIDGEH, 2006, 58 (04): : 297 - 319
  • [7] Where do we go?
    Priollet, P
    [J]. JOURNAL DES MALADIES VASCULAIRES, 1997, 22 (03) : 153 - 154
  • [8] Where Do We Go?
    Neal, Elizabeth
    [J]. LIBRARY JOURNAL, 1947, 72 (04) : 285 - 286
  • [9] ColVI myopathies: where do we stand, where do we go?
    Allamand, Valerie
    Brinas, Laura
    Richard, Pascale
    Stojkovic, Tanya
    Quijano-Roy, Susana
    Bonne, Gisele
    [J]. SKELETAL MUSCLE, 2011, 1
  • [10] Rye and health - Where do we stand and where do we go?
    Jonsson, Karin
    Andersson, Roger
    Knudsen, Knud Erik Bach
    Hallmans, Goran
    Hanhineva, Kati
    Katina, Kati
    Kolehmainen, Marjukka
    Kyro, Cecilie
    Langton, Maud
    Nordlund, Emilia
    Laerke, Helle Nygaard
    Olsen, Anja
    Poutanen, Kajsa
    Tjonneland, Anne
    Landberg, Rikard
    [J]. TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2018, 79 : 78 - 87